Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2Phase 3 Interventional

Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain

ClinicalTrials.gov ID: NCT04809376

Public ClinicalTrials.gov record NCT04809376. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 23, 2026, 7:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with subcutaneous injections of placebo in participants with knee osteoarthritis pain. Study details include: * The study duration will be up to 31 weeks per participant * The treatment duration will be 6 weeks. * The visit frequency will be twice weekly during treatment. * The visit frequency will be every 4 weeks during the follow-up period.

Study identification

NCT ID
NCT04809376
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2, Phase 3
Enrollment
602 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 18, 2021
Primary completion
Oct 14, 2024
Completion
Jan 5, 2025
Last update posted
Apr 7, 2024

2021 – 2025

United States locations

U.S. sites
29
U.S. states
10
U.S. cities
23
Facility City State ZIP Site status
Alliance for Multispecialty Research - Tempe Tempe Arizona 85281
Fiel Family and Sports Medicine Tempe Arizona 85283
Tucson Orthopaedic Institute Tucson Arizona 85712
Core Healthcare Group Cerritos California 90703
Biosolutions Clinical Research Center La Mesa California 91942
Providence Clinical Research North Hollywood California 91606
Prospective Research Innovations Inc. Rancho Cucamonga California 91730
Encompass Clinical Research Spring Valley California 91978
Clinical Research of West Florida- Clearwater Clearwater Florida 33765
University Clinical Research-Deland DeLand Florida 32720
LMG Research Miami Florida 33125
Well Pharma Medical Research, Corp. Miami Florida 33173
Progressive Medical Research Port Orange Florida 32127
Clinical Research of West Florida Tampa Florida 33606
Conquest Research Winter Park Florida 32789
Northwestern University Feinberg School of Medicine Chicago Illinois 60611
Alliance for Multispecialty Research - Newton Newton Kansas 67114
Alliance for Multispecialty Research - Wichita West Wichita Kansas 67205
Alliance for Multispecialty Research - Wichita East Wichita Kansas 67207
Tandem Clinical Research Marrero Louisiana 77072
Alliance for Multispecialty Research - Las Vegas Las Vegas Nevada 89119
Kaplan Medical Research Las Vegas Nevada 89119
Coastal Carolina Research Center North Charleston South Carolina 29405
Alliance for Multispecialty Research - Knoxville Knoxville Tennessee 37909
FutureSearch Trials - Austin Austin Texas 78731
Clinical Investigations of Texas Plano Texas 75075
Clinical Trials of Texas, Inc. San Antonio Texas 78229
Diagnostics Research Group - Northwest San Antonio San Antonio Texas 78229
Discovery Clinical Trials San Antonio Texas 78258

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04809376, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 7, 2024 · Synced Sep 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04809376 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →